AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 173 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $17,403,000 | -71.4% | 785,000 | -62.4% | 1.47% | -46.1% |
Q1 2022 | $60,840,000 | -11.4% | 2,090,000 | 0.0% | 2.73% | +40.9% |
Q4 2021 | $68,698,000 | -31.2% | 2,090,000 | -3.5% | 1.94% | -22.2% |
Q3 2021 | $99,915,000 | -16.3% | 2,165,000 | 0.0% | 2.49% | -17.9% |
Q2 2021 | $119,313,000 | +6.7% | 2,165,000 | 0.0% | 3.03% | -9.0% |
Q1 2021 | $111,801,000 | +8.6% | 2,165,000 | -8.8% | 3.33% | +9.2% |
Q4 2020 | $102,909,000 | +68.0% | 2,375,000 | +35.7% | 3.05% | +11.2% |
Q3 2020 | $61,250,000 | +7.0% | 1,750,000 | +63.6% | 2.74% | -19.0% |
Q2 2020 | $57,224,000 | +50.7% | 1,070,000 | 0.0% | 3.39% | -16.0% |
Q1 2020 | $37,964,000 | -3.6% | 1,070,000 | +29.7% | 4.03% | +11.2% |
Q4 2019 | $39,394,000 | -99.9% | 825,000 | -11.8% | 3.62% | +15.6% |
Q3 2019 | $30,294,000,000 | +22.7% | 935,000 | +88.9% | 3.14% | +35.7% |
Q2 2019 | $24,690,600,000 | +109189.1% | 495,000 | +47.8% | 2.31% | -6.9% |
Q1 2019 | $22,592,000 | +10.1% | 335,000 | -24.7% | 2.48% | -29.3% |
Q4 2018 | $20,519,000 | -54.1% | 445,000 | -23.2% | 3.51% | -35.4% |
Q3 2018 | $44,712,000 | +45.5% | 579,776 | +58.9% | 5.43% | +26.5% |
Q2 2018 | $30,725,000 | +3.0% | 364,776 | 0.0% | 4.30% | -18.1% |
Q1 2018 | $29,831,000 | +63.1% | 364,776 | +14.0% | 5.25% | +17.8% |
Q4 2017 | $18,294,000 | +7.5% | 320,000 | +25.5% | 4.46% | -7.3% |
Q3 2017 | $17,021,000 | +29.7% | 255,000 | 0.0% | 4.81% | -1.0% |
Q2 2017 | $13,120,000 | -5.4% | 255,000 | +7.4% | 4.85% | -40.7% |
Q1 2017 | $13,870,000 | +38.2% | 237,500 | -1.2% | 8.18% | -1.3% |
Q4 2016 | $10,036,000 | -32.7% | 240,500 | -14.9% | 8.29% | -31.4% |
Q3 2016 | $14,919,000 | +89.9% | 282,443 | +50.6% | 12.08% | +54.5% |
Q2 2016 | $7,855,000 | +30.7% | 187,500 | +26.7% | 7.82% | +13.4% |
Q1 2016 | $6,009,000 | -8.8% | 148,000 | +45.8% | 6.90% | +18.5% |
Q4 2015 | $6,590,000 | – | 101,500 | – | 5.82% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |